Clarithromycin
- Product NDC
- 68071-1899
- 11-digit product format
- 680711899
- Labeler code
- 68071
- Product ID
- 68071-1899_4b7dbff8-c9af-1d20-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clarithromycin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA065489
- Marketing category
- ANDA
- Marketing start
- 2012-07-25
- Marketing end
- 0000-00-00
- Substance
- CLARITHROMYCIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Macrolide Antimicrobial [EPC],Macrolides [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-1899-2 | 2020-08-05 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-3 | 2020-08-05 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-4 | 2020-08-05 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-8 | 2020-08-05 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |
| 68071-1899-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fd2e-f424-e053-dadaa90a57ce | 4b7dbff8-c9ae-1d20-e054-00144ff8d46c |